Pharma-Bio, Aerospace and Technology Projects Soften the Blow for Jacobs Engineering in First Quarter
Pharma-Bio, Aerospace and Technology Projects Soften the Blow for Jacobs Engineering in First Quarter
SUGAR LAND--February 4, 2016--Researched by Industrial Info Resources (Sugar Land, Texas)--Jacobs Engineering Group Incorporated (NYSE:JEC) (Pasadena, California) said its first-quarter 2016 earnings and project backlog were dampened by the slump in the Oil & Gas Industry, but added growth in the pharma-bio as well as strength in the aerospace and technology sectors helped soften the blow. Industrial Info is tracking 261 active projects worth $92.68 billion that involve Jacobs. Within this article: Details of first-quarter earnings results for Jacobs Engineering.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Alstom Secures Austrian Hydropower Deal
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips